Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Infection Rate

Doses used in studies

CFU/day: 1 billion (median 1 billion, IQR 1 billion–1 billion) — 1 study

Time to effect

Median: 4.3 weeks · IQR 4.3 weeks–4.3 weeks · Range 4.3 weeks–4.3 weeks — Reported in 1 of 1 study

1 of 1 paper

Effects of Lactobacillus rhamnosus GG on early postoperative outcome after pylorus-preserving pancreatoduodenectomy: a randomized trial.
- 2021-01-01
- RCT · n = 20
- European review for medical and pharmacological sciences 25(1)
- - M Folwarski
  - M Dobosz
  - S Małgorzewicz
  - K Skonieczna-Żydecka
  - K Kaźmierczak-Siedlecka
- PubMed: 33506929
- DOI: 10.26355/eurrev_202101_24407
7 Insights on
- Reduced Infection Rate
- High evidence
- Clinical
There were no significant differences in mortality and infectious complications between groups.
Effect
Neutral
Effect size
Small
Significant
No